CLINCAL OUTCOMES WITH ELEXACAFTOR/TEZACAFTOR/IVACAFTOR IN CYSTIC FIBROSIS PATIENTS WITH ADVANCED LUNG DISEASE

被引：0
|
作者：
Thompson, A. [1 ]
Djavid, R. [3 ]
Keating, C. [1 ]
DiMango, E. [1 ]
Altman, K. [2 ]
Gusman, E. [1 ]
机构：
[1] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA
[2] Columbia Univ, Dept Nutr, Irving Med Ctr, New York, NY USA
[3] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA
来源：
PEDIATRIC PULMONOLOGY | 2020年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
655
引用
收藏
页码：S294 / S295
页数：2
相关论文
共 50 条
  • [1] The efficacy of Elexacaftor/Tezacaftor/Ivacaftor in patients with cystic fibrosis and advanced lung disease
    O'Carroll, O. M.
    O'Shea, K. M.
    Carroll, C.
    Grogan, B.
    Connolly, A.
    O'Shaughnessy, L.
    Nicholson, T.
    Gallagher, C. G.
    McKone, E. F.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 1) : S16 - S16
  • [2] Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease
    O'Shea, Kate M.
    O'Carroll, Orla M.
    Carroll, Catherine
    Grogan, Brenda
    Connolly, Anna
    O'Shaughnessy, Lynda
    Nicholson, Trevor T.
    Gallagher, Charles G.
    McKone, Edward F.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (02)
  • [3] Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Advanced Cystic Fibrosis Lung Disease
    Djavid, Amir Reza
    Thompson, Alison E.
    Irace, Alexandria L.
    Gusman, Elen
    Altman, Kimberly
    DiMango, Emily A.
    Keating, Claire L.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (11) : 1924 - 1927
  • [4] Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease
    Hernandez, Laura Carrasco
    Moreno, Rosa Ma Giron
    Cartagena, Mari Nieves Balaguer
    Pelaez, Adrian
    Sole, Amparo
    Fernandez, Antonio Alvarez
    Montiel, Almudena Felipe
    Olveira, Casilda
    Olveira, Gabriel
    Bonilla, Ainhoa Gomez
    Crespo, Beatriz Gomez
    Clemente, Marta Garcia
    Garcia, Marta Solis
    Vazquez, Joana Quaresma
    Castro, Enrique Blitz
    Gonzalez, Jesus Rodriguez
    Marrero, Andrea Exposito
    Diab-Caceres, Laila
    Hernandez, Cristina Ramos
    de Lucas, Ester Zamarron
    Sanchez, Concha Prados
    Aparicio, Marina Blanco
    Neyra, Alejandro Lopez
    Santiago, Veronica Sanz
    Paredes, Carmen Luna
    Pecellin, Isabel Delgado
    de la Cruz, Oscar Asensio
    Gallego, Esther Quintana
    ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59 (09): : 556 - 565
  • [5] DISEASE MODULATION BY ELEXACAFTOR/TEZACAFTOR/IVACAFTOR IN CYSTIC FIBROSIS PATIENTS WITH SEVERE LUNG DISEASE
    Wright, E.
    Megram, E.
    Vardon, P.
    Cobb, R.
    Burgess, K.
    Moore, V
    Loel, F.
    Smith, D.
    Tay, G.
    France, M.
    Reid, D.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S221 - S222
  • [6] Impact of Elexacaftor-Tezacaftor-Ivacaftor on lung disease in cystic fibrosis
    Gushue, Courtney
    Eisner, Mariah
    Bai, Shasha
    Johnson, Terri
    Holtzlander, Melissa
    McCoy, Karen
    Sheikh, Shahid
    PEDIATRIC PULMONOLOGY, 2023, 58 (08) : 2308 - 2316
  • [7] Elexacaftor/Tezacaftor/Ivacaftor use in Pediatric Cystic Fibrosis Patients with Advanced Liver Disease
    Protich, Hannah E.
    Molleston, Jean P.
    Bozic, Molly
    Pettit, Rebecca S.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (06) : 1122 - 1128
  • [8] Multisystemic Effects of Elexacaftor-Tezacaftor-Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease
    Burgel, Pierre-Regis
    Paillasseur, Jean-Louis
    Durieu, Isabelle
    Reynaud-Gaubert, Martine
    Hamidfar, Rebecca
    Murris-Espin, Marlene
    Danner-Boucher, Isabelle
    Chiron, Raphael
    Leroy, Sylvie
    Douvry, Benoit
    Grenet, Dominique
    Mely, Laurent
    Ramel, Sophie
    Montcouquiol, Sylvie
    Burnet, Esperie
    Ouaalaya, El Hassane
    Sogni, Philippe
    Da Silva, Jennifer
    Martin, Clemence
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (07) : 1053 - 1064
  • [9] Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease
    Gramegna, Andrea
    Alicandro, Gianfranco
    Premuda, Chiara
    Lucca, Francesca
    Pinali, Lucia
    Retucci, Mariangela
    Vespro, Valentina
    Andrisani, Maria Carmela
    Carraffiello, Gianpaolo
    Amati, Francesco
    Volpi, Sonia
    Aliberti, Stefano
    Cipolli, Marco
    Blasi, Francesco
    CHEST, 2024, 166 (03) : 433 - 441
  • [10] ELEXACAFTOR/TEZACAFTOR/IVACAFTOR CLINICAL OUTCOMES IN PEDIATRIC AND ADULT CYSTIC FIBROSIS PATIENTS
    Teibel, H.
    Burrus, T.
    Loy, S.
    Taylor, A.
    Sorgen, P.
    Pettit, R. S.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S248 - S249
12345